Borge G Nordestgaard
Overview
Explore the profile of Borge G Nordestgaard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
842
Citations
49849
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Larsen L, Winther S, Korvel-Hanquist A, Marott S, Landt E, Homoe P, et al.
Eur Arch Otorhinolaryngol
. 2025 Mar;
PMID: 40087166
Objectives: α-Antitrypsin deficiency is a disease characterized by increased neutrophil elastase activity leading to tissue getting less elastic and robust. It is known that if tissue in the pharynx becomes...
2.
Nilausen K, Radutiu D, Landt E, Al-Shuweli S, Nordestgaard B, Bodtger U, et al.
J Asthma
. 2025 Mar;
:1-9.
PMID: 40065505
Background: Long-term consequences after a pulmonary embolism include lung function deficits, dyspnea, and chronic thromboembolic pulmonary hypertension. Recent studies suggest patients who experience pulmonary embolism may also be at increased...
3.
Luo J, Rasmussen I, Nordestgaard B, Tybjaerg-Hansen A, Thomassen J, Frikke-Schmidt R
Eur J Prev Cardiol
. 2025 Mar;
PMID: 40045558
Aims: Cardiovascular diseases (CVDs) have been linked to increased risk of dementia in observational studies, whereas genetic studies have yielded inconsistent findings. We aimed to determine whether nine CVDs are...
4.
Malick W, Choi D, Langsted A, Bittner V, Nordestgaard B, Stroes E, et al.
Eur J Prev Cardiol
. 2025 Mar;
PMID: 40043177
Low-density lipoprotein cholesterol (LDL-C) is the preeminent target for the prevention and treatment of atherosclerotic cardiovascular disease (ASCVD). Despite the expansive evidence supporting therapeutic reductions in LDL-C with statin therapy,...
5.
Kaltoft M, Afzal S, Nordestgaard B, Sigvardsen P, Kuhl J, Fuchs A, et al.
Eur J Prev Cardiol
. 2025 Mar;
PMID: 40036235
Aim: The only treatment available for aortic valve stenosis is valve replacement, which makes it important to identify modifiable risk factors. We tested the hypotheses that diabetes and elevated plasma...
6.
Benn M, Emanuelsson F, Tybjaerg-Hansen A, Nordestgaard B
Eur Heart J Open
. 2025 Feb;
5(1):oeaf009.
PMID: 39991120
Aims: Low levels of LDL cholesterol may be associated with risk of infectious disease. We tested the hypothesis that low LDL cholesterol due to genetic variation in the , ,...
7.
Riis J, Nordestgaard B, Afzal S
Eur J Prev Cardiol
. 2025 Feb;
PMID: 39982902
Aims: High remnant cholesterol has been increasingly recognized as an important risk factor for atherosclerotic cardiovascular disease (ASCVD). However, uncertainty remains regarding this association in old age. The aim of...
8.
Kobylecki C, Nordestgaard B, Afzal S
J Clin Endocrinol Metab
. 2025 Feb;
PMID: 39973298
Background: Although it is generally held that in otherwise healthy individuals, primary hyperparathyroidism is the most likely cause of persistent hypercalcemia, solid research supporting this assumption is absent. We aimed...
9.
Vangedal M, Thuraiaiyah J, Joergensen T, Joergensen T, Solis A, Langsted A, et al.
Int J Cardiol
. 2025 Feb;
425:133032.
PMID: 39956458
Introduction: Adults with congenital heart disease (ACHD) are at increased risk of premature atherosclerotic cardiovascular disease. Obesity is an independent risk factor for a number of cardiometabolic diseases including atherosclerotic...
10.
Toft-Nielsen F, Emanuelsson F, Nordestgaard B, Benn M
Eur J Intern Med
. 2025 Feb;
PMID: 39952815
Background: Individuals with familial hypercholesterolemia (FH) are at high risk of developing cardiovascular disease due to high LDL cholesterol concentrations. Other cardiovascular risk factors may add to this risk. Methods:...